ONE-YEAR OUTCOME OF EVEROLIMUS-ELUTING STENTS VERSUS BIOLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ALIDOOSTI MOHAMMAD; SHARIFNIA VAHIDEH; KASSAIAN SEYED EBRAHIM; HAJIZEINALI ALIMOHAMMAD; POORHOSSEINI HAMIDREZA; SALARIFAR MOJTABA; NOZARI YOUNES; HAKKI KAZAZI ELHAM

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: THE JOURNAL OF TEHRAN UNIVERSITY HEART CENTER Year:2016 | Volume:11 | Issue:2 Page(s): 62-67

Download Full-Text

View:

293

Download:

Cites:

Information Journal Paper

Title

ONE-YEAR OUTCOME OF EVEROLIMUS-ELUTING STENTS VERSUS BIOLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

Author(s)

Keywords

BIOLIMUS-A9

EVEROLIMUS

STENTS

DRUG-ELUTING STENTS

OUTCOME ASSESSMENT

Abstract

Background: The biolimus-eluting stent (BES), with a biodegradable polymer, has not been previously compared with the EVEROLIMUS-eluting stent (EES), as a second-generation drug-eluting stent (DES).We sought to compare the 1-year outcome between the PROMUS™ stent (EES type) and the BioMatrix™ stent (BES type).Methods: From March 2008 to September 2011, all patients treated with the PROMUS™ stent or the Bio Matrix™ stent for coronary artery stenosis at Tehran Heart Center were enrolled. The primary end points were 1-year adverse events, comprising death, myocardial infarction, target vessel revascularization, and target lesion revascularization. The secondary end point was stent thrombosis. The Cox proportional hazard model was used to assess the adjusted association between the stent type and the follow-up outcome.Results: From 949 patients (66.3% male, mean age=59.48 ± 10.46 y) with 1, 018 treated lesions, 591 patients (630 lesions, 65.1% male, mean age=59.24 ± 10.23 y) received the PROMUS™stent and 358 patients (388 lesions, 68.2% male, mean age=59.88 ± 10.83 y) were treated with the BioMatrix™stent. Before adjustment, the rate of the primary end points was 3.2% and 3.4% in the EES and BES, respectively (p value=0.925, HR (EES to BES) =1.035, 95% CI: 0.50 to 2.13). The rate of stent thrombosis was 2% and 1.7% in the EES and BES, respectively (p value=0.698). After adjustment on confounder variables, there was no statistically significant difference in major adverse cardiac events between the PROMUS™ stent and the Bio Matrix™ stent (p value=0.598, HR (EES to BES) =0.817, 95% CI: 0.39 to 1.73). Conclusion: At 1 year’s follow-up, the BES and EES showed similar safety and efficacy rates in the patients undergoing percutaneous coronary intervention with a relatively low rate of adverse events in the 2 groups.

Cites

No record.

References

No record.

Cite

APA: Copy

ALIDOOSTI, MOHAMMAD, SHARIFNIA, VAHIDEH, KASSAIAN, SEYED EBRAHIM, HAJIZEINALI, ALIMOHAMMAD, POORHOSSEINI, HAMIDREZA, SALARIFAR, MOJTABA, NOZARI, YOUNES, & HAKKI KAZAZI, ELHAM. (2016). ONE-YEAR OUTCOME OF EVEROLIMUS-ELUTING STENTS VERSUS BIOLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. THE JOURNAL OF TEHRAN UNIVERSITY HEART CENTER, 11(2), 62-67. SID. https://sid.ir/paper/302037/en

Vancouver: Copy

ALIDOOSTI MOHAMMAD, SHARIFNIA VAHIDEH, KASSAIAN SEYED EBRAHIM, HAJIZEINALI ALIMOHAMMAD, POORHOSSEINI HAMIDREZA, SALARIFAR MOJTABA, NOZARI YOUNES, HAKKI KAZAZI ELHAM. ONE-YEAR OUTCOME OF EVEROLIMUS-ELUTING STENTS VERSUS BIOLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. THE JOURNAL OF TEHRAN UNIVERSITY HEART CENTER[Internet]. 2016;11(2):62-67. Available from: https://sid.ir/paper/302037/en

IEEE: Copy

MOHAMMAD ALIDOOSTI, VAHIDEH SHARIFNIA, SEYED EBRAHIM KASSAIAN, ALIMOHAMMAD HAJIZEINALI, HAMIDREZA POORHOSSEINI, MOJTABA SALARIFAR, YOUNES NOZARI, and ELHAM HAKKI KAZAZI, “ONE-YEAR OUTCOME OF EVEROLIMUS-ELUTING STENTS VERSUS BIOLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION,” THE JOURNAL OF TEHRAN UNIVERSITY HEART CENTER, vol. 11, no. 2, pp. 62–67, 2016, [Online]. Available: https://sid.ir/paper/302037/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops